Liposome Tech regulatory update

LTIZ (Menlo Park, Calif.) filed in the 12 European Union nations for marketing approval of DOX-SL to treat AIDS-related Kaposi's sarcoma. DOX-SL is LTIZ's long-circulating STEALTH liposome formulation...